For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251203:nRSC9369Ja&default-theme=true
RNS Number : 9369J UIL Limited 03 December 2025
3 December 2025
UIL LIMITED
(LEI Number: 213800CTZ7TEIE7YM468)
End of the 2025 Share Liquidity Programme
The Board of UIL Limited ("UIL" or the "Company") announced on 5 November 2025
the commencement of the 2025 Share Liquidity Programme (the "Programme").
The Programme comprised a facility to purchase in the market, over a four week
period, the Company's ordinary shares of 10p each ("Ordinary Shares") at a
discount of approximately 20% to the most recently announced daily net asset
value ("NAV"), up to a maximum aggregate consideration of £4.0 million and
subject to daily limits.
The Board is pleased to report that there was strong shareholder support for
the Programme. A total of 1,939,098 Ordinary Shares were purchased for
cancellation pursuant to the Programme for an aggregate consideration of
£3.5m.
The Programme delivered on the Board's commitment to provide an annual
opportunity for minority shareholders to exit a significant proportion of
their shares at a discount of approximately 20% to NAV in advance of the
proposal to take UIL private in 2028 at a share price close to NAV at that
time. It is expected that similar share liquidity programmes will operate in
2026 and 2027. In addition, the Company may also acquire Ordinary Shares in
the market pursuant to the Company's annual general authority to repurchase
shares, subject to available cash resources.
Name of contact and telephone number for enquiries:
Joint Portfolio Manager and Company Secretary
ICM Investment Management Limited / ICM Limited
Charles Jillings / Alastair
Moreton
+44 (0)1372 271486
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCPKBBKPBDDDBK
Copyright 2019 Regulatory News Service, all rights reserved